Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2008 2
2013 1
2017 1
2018 2
2019 1
2020 3
2021 3
2022 8
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.
Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Kirste S, Jacobasch L, Allgäuer M, Flentje M, Germer CT, Grützmann R, Hildebrandt G, Schwarzbach M, Bechstein WO, Sülberg H, Friede T, Gaedcke J, Ghadimi M, Hofheinz RD, Rödel C; German Rectal Cancer Study Group. Fokas E, et al. JAMA Oncol. 2022 Jan 1;8(1):e215445. doi: 10.1001/jamaoncol.2021.5445. Epub 2022 Jan 20. JAMA Oncol. 2022. PMID: 34792531 Free PMC article. Clinical Trial.
Towards individualized radiation therapy in multiple myeloma.
Momm F, Greil C, Schäfer H. Momm F, et al. Among authors: schafer h. Haematologica. 2020 Jul;105(7):1763-1764. doi: 10.3324/haematol.2019.243451. Haematologica. 2020. PMID: 32611577 Free PMC article. No abstract available.
App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial.
Sprave T, Pfaffenlehner M, Stoian R, Christofi E, Rühle A, Zöller D, Fabian A, Fahrner H, Binder H, Schäfer H, Gkika E, Grosu AL, Heinemann F, Nicolay NH. Sprave T, et al. Among authors: schafer h. J Med Internet Res. 2023 Oct 19;25:e46189. doi: 10.2196/46189. J Med Internet Res. 2023. PMID: 37856185 Free PMC article. Clinical Trial.
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.
Tawk B, Wirkner U, Schwager C, Rein K, Zaoui K, Federspil PA, Adeberg S, Linge A, Ganswindt U, Hess J, Unger K, Tinhofer I, Budach V, Lohaus F, Krause M, Guberina M, Stuschke M, Balermpas P, Rödel C, Grosu AL, Schäfer H, Zips D, Combs SE, Pigorsch S, Zitzelsberger H, Baumeister P, Kirchner T, Bewerunge-Hudler M, Weichert W, Hess J, Herpel E, Belka C, Baumann M, Debus J, Abdollahi A; DKTK-ROG. Tawk B, et al. Among authors: schafer h. Int J Cancer. 2022 Feb 15;150(4):603-616. doi: 10.1002/ijc.33842. Epub 2021 Nov 8. Int J Cancer. 2022. PMID: 34648658 Free article.
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy.
Patil S, Tawk B, Grosser M, Lohaus F, Gudziol V, Kemper M, Nowak A, Haim D, Tinhofer I, Budach V, Guberina M, Stuschke M, Balermpas P, Rödel C, Schäfer H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Boeke S, Zips D, Baretton GB, Baumann M, Krause M, Löck S, Linge A; DKTK-ROG. Patil S, et al. Among authors: schafer h. Radiother Oncol. 2022 Feb;167:300-307. doi: 10.1016/j.radonc.2021.12.049. Epub 2022 Jan 6. Radiother Oncol. 2022. PMID: 34999136
Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma.
Thurner L, Preuss KD, Bewarder M, Kemele M, Fadle N, Regitz E, Altmeyer S, Schormann C, Poeschel V, Ziepert M, Walter S, Roth P, Weller M, Szczepanowski M, Klapper W, Monoranu C, Rosenwald A, Möller P, Hartmann S, Hansmann ML, Mackensen A, Schäfer H, Schorb E, Illerhaus G, Buslei R, Bohle RM, Stilgenbauer S, Kim YJ, Pfreundschuh M. Thurner L, et al. Among authors: schafer h. Blood. 2018 Dec 27;132(26):2744-2753. doi: 10.1182/blood-2018-03-836932. Epub 2018 Sep 24. Blood. 2018. PMID: 30249786 Free article.
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers.
Frank B, Ihorst G, Herget G, Schäfer H, Neubauer J, Calba MA, Textor D, Möller MD, Wenger S, Jung J, Waldschmidt J, Miething C, Rassner M, Greil C, Wäsch R, Engelhardt M. Frank B, et al. Among authors: schafer h. Ann Hematol. 2023 Mar;102(3):603-611. doi: 10.1007/s00277-022-05051-y. Epub 2022 Dec 5. Ann Hematol. 2023. PMID: 36464695 Free PMC article.
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT.
Patil S, Linge A, Hiepe H, Grosser M, Lohaus F, Gudziol V, Kemper M, Nowak A, Haim D, Tinhofer I, Budach V, Guberina M, Stuschke M, Balermpas P, Grün JV, Schäfer H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Boeke S, Zips D, Jöhrens K, Baretton GB, Baumann M, Krause M, Löck S, On Behalf Of The Dktk-Rog. Patil S, et al. Among authors: schafer h. Cancers (Basel). 2022 Jun 20;14(12):3031. doi: 10.3390/cancers14123031. Cancers (Basel). 2022. PMID: 35740697 Free PMC article.
30 results